The Wuhan company didn’t bother with the dark web. It spruiked its goods right in the open, showing mounds of white powder ...

A Queens man is accused of stealing $100,000 worth of commercial kitchen equipment from a Carle Place store over a two-month ...

chief commercial officer for Protega Pharmaceuticals, which recently won approval for an abuse-deterrent opioid. The opportunity for drugmakers to develop better pain management alternatives is ...

New Monash University research has revealed a concerning rise in new opioid prescriptions among younger Victorians, while also finding an overall positive trend, with a drop in opioid prescription ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S ...

Shares of Vertex Pharmaceuticals VRTX2.07%increase; green up pointing triangle rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug Administration approval.

Here's how it could help fight the opioid crisis. Zelensky back on track ... These Are The Longest Commercial Airport Runways In The US NBA All-Star Weekend 2025: Live results, updates from ...

JAN 31 – A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name ...

A Quebec coroner says the 2023 death of 15-year-old Mathis Boivin should be "sounding the alarm" on the importance of preventing opioid use and dependency among young people. Coroner Stéphanie ...

WASHINGTON — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.

“Over 600 times last year in the state of Utah, someone came home and found their son, daughter or parent deceased from an opioid overdose,” Rep. Matthew Gwynn, R-Farr West, the bill’s sponsor, said ...

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s owners and members of the Sackler family for their role in the opioid crisis.